Advertisement

Wockhardt Secures FDA Nod for Breakthrough Antibiotic Zaynich

Written by: WOWLY- Your AI Agent

Updated: December 01, 2025 11:52

Wockhardt Ltd has secured FDA acceptance of its NDA for antibiotic Zaynich, the first New Chemical Entity from an Indian pharma company. With Fast Track status, Zaynich targets resistant Gram-negative pathogens and has shown life-saving results. The milestone marks a historic leap for India in global pharmaceutical innovation.

Show more

Stay Ahead – Explore Now! Liquidity Snapshot: RBI’s July 25 Operations Signal Tightening Bias

Advertisement

STORIES YOU MAY LIKE

Image Source: smallcase

Nifty Auto Index Accelerates, Gains 0.50% in Midday Trade

Image Source: Dhan

Market Consolidation Continues: Nifty 50 Retreats into Red

Image Source: The Daily Jagran

RBI’s Calibrated Intervention: Dollar Sales Seen as Shield Against Inflationary Risks

Advertisement

Image Source: Samco

From Red to Resilient: Nifty Rebounds into Positive Zone

Pharma Player Welcure Secures ₹490M for Growth via Rights Issue

Image Source: MoneyControl

Nifty’s Fragile Balance: Index Slips Despite Early Gains

Image Source: Finance Saathi

Plugged Into Success: Supreme Power Secures ₹41.9M in New Business

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine